NICOTERA, GIUSEPPE
NICOTERA, GIUSEPPE
FARMACOLOGIA TRASLAZIONALE - IFT
Bioassay-guided Isolation of Nigracin, responsible for the Tissue Repair properties of Drypetes klainei Stem Bark.
2020 Sferrazza, G; Corti, M; Andreola, F; Giovannini, D; Nicotera, G; Zonfrillo, M; Serra, M; Tengattini, S; Calleri, E; Brusotti, G; Pierimarchi, P; Serafino, A
Suspected adverse drug reactions (ADRs) trends in older Italian patients: an analysis from the National Pharmacovigilance Network
2019 Sferrazza, G; Nicotera, G; Pierimarchi, P
The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach
2019 Nicotera, Giuseppe; Sferrazza, Gianluca; Serafino, Annalucia; Pierimarchi, Pasquale
Atrial Natriuretic Peptide Acts As a Neuroprotective Agent in In Vitro Models of Parkinson's Disease via Up-Regulation of the Wnt/ß-Catenin Pathway
2018 Colini Baldeschi, Arianna; Pittaluga, Eugenia; Andreola, Federica; Rossi, Simona; Cozzolino, Mauro; Nicotera, Giuseppe; Sferrazza, Gianluca; Pierimarchi, Pasquale; Serafino, Annalucia
Synergistic antiproliferative and differentiating effect of 2,4-monofurfurylidene-tetra-O-methylsorbitol and 4,6-dimethyl-2-(3,4,5-trimethoxyphenylamino)pyrimidine on primary and immortalized keratinocytes
2018 Serafino, A; Nicotera, G; Andreola, F; Giovannini, D; Zonfrillo, M; Sferrazza, G; Calcaterra, A; De Angelis, C; Camponeschi, C; Pierimarchi, P
Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases
2017 Serafino, A; Sferrazza, G; Colini Baldeschi, A; Nicotera, G; Andreola, F; Pittaluga, E; Pierimarchi, P
Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations.
2017 Sferrazza, Gianluca; Siviero Paolo, D; Nicotera, Giuseppe; Turella, Paola; Serafino, Annalucia; Blandizzi, Corrado; Pierimarchi, Pasquale
Appropriatezza prescrittiva e pazienti anziani: serve un cambio di rotta? About Pharma and Medical Device; Luglio 2016.
2016 Pierimarchi, Pasquale; Sferrazza, G; Nicotera, G.
In vitro evaluation of the wound healing activity of Drypetes klainei stem bark extracts
2015 Brusotti, G; Andreola, F; Sferrazza, G; Grisoli, P; Merelli, A; Cuna, Fsrd; Calleri, E; Nicotera, G; Pierimarchi, P; Serafino, A
Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells
2015 Lucibello, Maria; Adanti, Sara; Antelmi, Ester; Dezi, Dario; Ciafrè, Stefania; Carcangiu Maria, Luisa; Zonfrillo, Manuela; Nicotera, Giuseppe; Sica, Lorenzo; De Braud Filippo, De; Pierimarchi, Pasquale
Thymosin alfa1 modifies podosome architecture and promptly stimulates the expression of podosomal markers in mature macrophage
2015 Serafino, Annalucia; Andreola, Federica; Pittaluga, Eugenia; K Krasnowska, Ewa; Nicotera, Giuseppe; Sferrazza, Gianluca; Sinibaldivallebona, Paola; Pierimarchi, Pasquale; Garaci, Enrico
WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in Inflammatory Bowel Disease and sporadic colorectal cancer
2014 SERAFINO A.; Moroni N.; Zonfrillo M.; Andreola F.; Mercuri L.; Nicotera G.; Nunziata J.; Ricci R.; Antinori A.; Rasi G.; Pierimarchi P
Rapid Chagas diagnosis in clinical settings using a multiparametric assay.
2013 Pierimarchi, P; Cerni, L; Alarcón de Noya, B; Nicotera, G; Díazbello, Z; Angheben, A; Scacciatelli, D; Zonfrillo, M; Recinelli, G; Serafino, A
"Anti-inflammatory Effect of Resveratrol and Polydatin by In Vitro IL-17 Modulation"
2011 Lanzilli, G; Cottarelli, A; Nicotera, G; Guida, S; Ravagnan, G; Fuggetta, Mp
Anti-inflammatory Effect of Resveratrol and Polydatin by In Vitro IL-17 Modulation.
2011 Lanzilli, G; Cottarelli, A; Nicotera, G; Guida, S; Ravagnan, G; Fuggetta, Mp
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bioassay-guided Isolation of Nigracin, responsible for the Tissue Repair properties of Drypetes klainei Stem Bark. | 1-gen-2020 | Sferrazza, G; Corti, M; Andreola, F; Giovannini, D; Nicotera, G; Zonfrillo, M; Serra, M; Tengattini, S; Calleri, E; Brusotti, G; Pierimarchi, P; Serafino, A | |
| Suspected adverse drug reactions (ADRs) trends in older Italian patients: an analysis from the National Pharmacovigilance Network | 1-gen-2019 | Sferrazza, G; Nicotera, G; Pierimarchi, P | |
| The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach | 1-gen-2019 | Nicotera, Giuseppe; Sferrazza, Gianluca; Serafino, Annalucia; Pierimarchi, Pasquale | |
| Atrial Natriuretic Peptide Acts As a Neuroprotective Agent in In Vitro Models of Parkinson's Disease via Up-Regulation of the Wnt/ß-Catenin Pathway | 1-gen-2018 | Colini Baldeschi, Arianna; Pittaluga, Eugenia; Andreola, Federica; Rossi, Simona; Cozzolino, Mauro; Nicotera, Giuseppe; Sferrazza, Gianluca; Pierimarchi, Pasquale; Serafino, Annalucia | |
| Synergistic antiproliferative and differentiating effect of 2,4-monofurfurylidene-tetra-O-methylsorbitol and 4,6-dimethyl-2-(3,4,5-trimethoxyphenylamino)pyrimidine on primary and immortalized keratinocytes | 1-gen-2018 | Serafino, A; Nicotera, G; Andreola, F; Giovannini, D; Zonfrillo, M; Sferrazza, G; Calcaterra, A; De Angelis, C; Camponeschi, C; Pierimarchi, P | |
| Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases | 1-gen-2017 | Serafino, A; Sferrazza, G; Colini Baldeschi, A; Nicotera, G; Andreola, F; Pittaluga, E; Pierimarchi, P | |
| Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations. | 1-gen-2017 | Sferrazza, Gianluca; Siviero Paolo, D; Nicotera, Giuseppe; Turella, Paola; Serafino, Annalucia; Blandizzi, Corrado; Pierimarchi, Pasquale | |
| Appropriatezza prescrittiva e pazienti anziani: serve un cambio di rotta? About Pharma and Medical Device; Luglio 2016. | 1-gen-2016 | Pierimarchi, Pasquale; Sferrazza, G; Nicotera, G. | |
| In vitro evaluation of the wound healing activity of Drypetes klainei stem bark extracts | 1-gen-2015 | Brusotti, G; Andreola, F; Sferrazza, G; Grisoli, P; Merelli, A; Cuna, Fsrd; Calleri, E; Nicotera, G; Pierimarchi, P; Serafino, A | |
| Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells | 1-gen-2015 | Lucibello, Maria; Adanti, Sara; Antelmi, Ester; Dezi, Dario; Ciafrè, Stefania; Carcangiu Maria, Luisa; Zonfrillo, Manuela; Nicotera, Giuseppe; Sica, Lorenzo; De Braud Filippo, De; Pierimarchi, Pasquale | |
| Thymosin alfa1 modifies podosome architecture and promptly stimulates the expression of podosomal markers in mature macrophage | 1-gen-2015 | Serafino, Annalucia; Andreola, Federica; Pittaluga, Eugenia; K Krasnowska, Ewa; Nicotera, Giuseppe; Sferrazza, Gianluca; Sinibaldivallebona, Paola; Pierimarchi, Pasquale; Garaci, Enrico | |
| WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in Inflammatory Bowel Disease and sporadic colorectal cancer | 1-gen-2014 | SERAFINO A.; Moroni N.; Zonfrillo M.; Andreola F.; Mercuri L.; Nicotera G.; Nunziata J.; Ricci R.; Antinori A.; Rasi G.; Pierimarchi P | |
| Rapid Chagas diagnosis in clinical settings using a multiparametric assay. | 1-gen-2013 | Pierimarchi, P; Cerni, L; Alarcón de Noya, B; Nicotera, G; Díazbello, Z; Angheben, A; Scacciatelli, D; Zonfrillo, M; Recinelli, G; Serafino, A | |
| "Anti-inflammatory Effect of Resveratrol and Polydatin by In Vitro IL-17 Modulation" | 1-gen-2011 | Lanzilli, G; Cottarelli, A; Nicotera, G; Guida, S; Ravagnan, G; Fuggetta, Mp | |
| Anti-inflammatory Effect of Resveratrol and Polydatin by In Vitro IL-17 Modulation. | 1-gen-2011 | Lanzilli, G; Cottarelli, A; Nicotera, G; Guida, S; Ravagnan, G; Fuggetta, Mp |